Michael Patrick Miller - 11 Jun 2026 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Reporting relationship: Director
Issuer ticker: PBYI
Reported as of: 11 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2026, 20:12:13 UTC
Prior SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Gordon Esplin as attorney-in-fact for Michael Patrick Miller

Key filing fact

Michael Patrick Miller filed Form 4 for PUMA BIOTECHNOLOGY, INC. (PBYI) on 15 Jun 2026.

Key facts

This page summarizes Michael Patrick Miller's Form 4 filing for PUMA BIOTECHNOLOGY, INC. (PBYI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jun 2026, 20:12.

Change

Previous filing in this sequence was filed on 19 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001236514 Primary reporting owner

MILLER MICHAEL PATRICK

Relationship: Director
Address: C/O PUMA BIOTECHNOLOGY, INC., 10880 WILSHIRE BLVD., SUITE 1700, LOS ANGELES
Signature: /s/ Gordon Esplin as attorney-in-fact for Michael Patrick Miller
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PBYI transaction

Common Stock

Award

Transaction value
Shares: +27,000
Change %: +50%
Price: $0.000000^*
Shares after: 81,000
Date: 11 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.